Cellectar Biosciences

CLRBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$20.539 M

$2.57 +1.98%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$21.8M

Loss-making

Shares outstanding

4,240,129

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#394Dare BioscienceDARE$21.0M
#395Neuphoria TherapeuticsNEUP$20.6M
#396Cellectar BiosciencesCLRB$20.5M
#397Atossa TherapeuticsATOS$20.3M
#398CelularityCELU$20.3M

Where these numbers come from

Share counts and financials for Cellectar Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.